ClinicalTrials.gg
RecruitingNCT07191795PhantomWalkUpdated Nov 3, 2026

Uses of Phantom Sensations Induced by Global and Local Modifications of the Prosthetic Socket as Somatosensory Feedback During Walking in Lower Limb Amputees

An interventional study of Gait analysis and Mapping of referred sensations. in Lower Limb Amputation, sponsored by Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est. Recruiting at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Sep 2024, registered Aug 2025).
  • Started Sep 2024; still recruiting 2 years 2 months later.
Updated Nov 3, 2026Enrollment updatedPrimary outcomes revised+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
248
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

Following lower-limb amputation, the loss of somatosensory information from the missing limb renders walking less automatic, more cognitively demanding, and often asymmetric, which can lead to secondary pathologies.

Hypothesis: This study is based on the hypothesis that phantom limb sensations (PLS), when coherent with the prosthetic device's movements and the phases of the gait cycle, can compensate for the loss of somatosensory feedback and thereby improve locomotion for individuals with amputation. It is further hypothesized that it is possible to artificially induce these coherent and useful sensations, notably through "referred sensations" elicited by stimulation of the residual limb (e.g., via the prosthetic socket).

Objectives: The project aims to:

  • Determine whether the natural presence of phantom limb sensations during walking impacts gait parameters.
  • Confirm in a larger patient population that modifications to the prosthetic socket can induce or enhance phantom sensations that are perceived as useful for walking.
  • Investigate whether these perceptual changes (induced or enhanced) are associated with objective, measurable improvements in gait quality.
02

Conditions studied

  • Lower Limb Amputation

Keywords

  • Phantom Limb Sensation
  • Referred Sensation
  • Somatosensory Feedback
  • Lower Limb Prosthesis
  • Prosthetic Gait
03

In context

Lead sponsor

Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est is the lead sponsor of 14 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants with amputations:

    • Major lower limb amputation
    • Understand and be able to express oneself in the French language (for semi-structured interviews)
    • Affiliated with a social security scheme
  • Asymptomatic volunteer participants:

    • No major surgery on the lower limbs for at least 3 years
    • No minor injury to the trunk, lower or upper limbs that could influence walking for at least 1 year
    • Understand and be able to express oneself in the French language
    • Affiliated with a social security scheme

Exclusion criteria

Exclusion Criteria:

  • History of psychiatric disorders
  • Pregnant or breastfeeding woman
  • Minor
  • Adult subject to a legal protection measure
  • Person under guardianship or conservatorship
  • Person under a judicial protection order
  • Pain affecting walking (trunk, residual limb, phantom limb, contralateral limb)
  • Medical treatment incompatible with walking
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
248 participants (estimated)

Study arms

  • Experimental
    Amputees w-o SF

    People without fantom sensation during gait

    Other: Gait analysis · Other: Mapping of referred sensations. · Other: Phantom limb interview

  • Experimental
    Amputees H-SF

    People with phantom sensations who are caregivers

    Other: Gait analysis · Other: Mapping of referred sensations. · Other: Evaluation of the effects of socket modifications on phantom sensations and walking · Other: Phantom limb interview

  • Experimental
    Control

    Asymptomatic people

    Other: Gait analysis

  • Experimental
    Amputees B-SF

    People with bothersome phantom sensations

    Other: Gait analysis · Other: Mapping of referred sensations. · Other: Evaluation of the effects of socket modifications on phantom sensations and walking · Other: Phantom limb interview

  • Experimental
    Amputees N-SF

    People with neutral phantom sensations

    Other: Gait analysis · Other: Mapping of referred sensations. · Other: Evaluation of the effects of socket modifications on phantom sensations and walking · Other: Phantom limb interview

Interventions

  • OtherGait analysis

    Participants with unilateral amputations and a control group will undergo a comprehensive walking analysis. In a lab setting (on a treadmill or floor), their gait will be recorded using inertial sensors, EMG, force plates, and motion capture, while an EEG cap and a NASA-TLX questionnaire will assess cognitive load. Capable participants will also perform a walking test on a real-world outdoor course with varied terrain. The data will be analyzed to compare walking patterns between groups (amputees vs. controls, and amputees with vs. without phantom limbs). Finally, participants will describe any interactions they perceived between their phantom sensations and walking during the tests.

  • OtherMapping of referred sensations.

    Participants reporting referred sensations in gait analysis phase will undergo further testing. The study will investigate whether prosthesis pressure or a specific socket interaction causes these sensations. A 3x3 cm grid will be drawn on the residual limb to systematically map referred sensations using various stimuli (brush, pressure tip, electrical stimulation). Participants will rate the intensity and describe the location of any resulting phantom sensations. This mapping will be repeated after 6 months to assess the stability of these sensations over time, with the ultimate goal of potentially using them to provide sensory feedback for prosthesis users. The session will last approximately 2 hours.

  • OtherEvaluation of the effects of socket modifications on phantom sensations and walking

    In 10 unilateral transfemoral amputees with stable induced phantom sensations, this phase evaluates how a personalized socket modification affects phantom sensations and walking. With the prosthetist, a localized thickness (e.g., silicone insert) is added inside the usual socket at the stable stimulation sites identified on the residual-limb map, after measuring socket pressure with a thin sensor array. Each participant is tested in two conditions in a fixed order: usual socket first, then modified socket. The order is not randomized because induced sensations may persist after the modification is removed. For each condition, gait is analyzed in the laboratory and on the ecological course (4 sessions; conditions no more than 4 weeks apart). Participants describe their sensations, rate cognitive load, effort and socket comfort, and indicate which condition is most helpful for walking.

  • OtherPhantom limb interview

    A semi-structured interview will be conducted to ask participants to describe their phantom limb sensations (type, location, intensity) under three conditions: without their prosthesis, while standing with it, and while walking with it. This aims to identify factors influencing these sensations. Additionally, a brief physical examination of the residual limb will be performed to see if touch in specific areas triggers any referred sensations.

06

What researchers measure

Primary outcomes

  1. Prevalence of non-painful phantom sensations during walking

    Proportion of amputee participants able to walk who report non-painful phantom sensations during walking, collected during a standardized semi-structured interview. Reported as a proportion with its exact (Clopper-Pearson) 95% confidence interval

    Time frame: The first day of the study

  2. Double support time during level walking at self-selected speed

    Double support time, defined as the sum of the initial and terminal double support periods of the prosthetic-limb gait cycle, expressed as a percentage of gait cycle duration (%). Measured by 3D motion analysis and force plates during level overground walking at self-selected speed in the laboratory (spontaneous condition).

    Time frame: The first day of the study for the control group and the second day of the study for participants with amputation

  3. Within-participant difference in double support time between usual and modified socket

    Difference in double support time (% of gait cycle, same definition and walking condition as Phase 2) between walking with the usual socket and walking with the socket modified by a focal thickness addition designed to induce phantom sensations, in transfemoral amputees. Conditions assessed in a fixed order (usual socket first). Reported as mean difference with 95% confidence interval.

    Time frame: Days 4 to 7 of the study

Secondary outcomes

  1. Walking pace under laboratory conditions

    The number of steps per minute (steps/min) when walking at a comfortable speed. Measured using inertial measurement units or the Vicon system.

    Time frame: The first day of the study for the control group and the second day of the study for participants with amputation

  2. Analysis of brain activity related to cognitive load during walking

    Electroencephalographic (EEG) activity will be recorded via a headset. Cognitive load will be quantified by analyzing the power ratio in specific frequency bands at the frontal electrodes.

    Time frame: The second day of the study for participants with amputation

  3. Gait speed in ecological situation

    The average walking speed (in m/s) measured using inertial measurement units and pressure soles (Loadsol) during a predefined outdoor route including various difficulties (stairs, slopes, etc.).

    Time frame: The first day of the study for the control group and the second day of the study for participants with amputation

  4. Qualitative description of the interaction between phantom sensations and walking

    Participants' verbal descriptions of the nature of the interaction (facilitating, hindering, neutral), the evolution and characteristics of phantom sensations during walking will be collected via a structured interview at the end of the session. The data will be analyzed thematically.

    Time frame: The second day of the study for participants with amputation

  5. Effect of focal stimulation on phantom sensations

    For the subgroup of participants reporting interaction between sensations and focal stimulation after various stimulations using a rubber tip (pressure), a brush, and a needle. The change in sensation intensity (rated on a scale of 0 to 5). The result will be categorized as "increase," "decrease," or "no change."

    Time frame: Day 3 of the study

  6. Change in perceived cognitive load (NASA-TLX score) during walking in an ecological setting

    Perceived mental workload will be assessed using the NASA-TLX questionnaire immediately after each walking session. The total score will be compared between the four socket conditions.

    Time frame: Day 4 to 7 of the study

  7. Evaluation of socket comfort

    The overall comfort perceived for each condition will be assessed at the end of each session using a Numerical Rating Scale (NRS) ranging from 0 (very uncomfortable) to 10 (very comfortable). The average score will be compared between the four conditions.

    Time frame: Day 4 to 7 of the study

  8. Assessment of mental workload during walking using the NASA-TLX questionnaire

    The cognitive load perceived by the participant will be assessed using the NASA Task Load Index (NASA-TLX) self-report questionnaire. The total score, ranging from 0 to 100, will be calculated. A higher score indicates a greater perceived cognitive load.

    Time frame: The first day of the study for the control group and the second day of the study for participants with amputation

  9. Qualitative description of the sensations reported for each socket condition

    For each condition, a structured description of the sensations reported (type, location, intensity, perceived usefulness for walking) will be collected through an interview. The data will be analyzed thematically to compare the sensory experience.

    Time frame: Day 4 to 7 of the study

  10. Change in phantom limb sensation intensity at 6 months for recent amputees

    For the subgroup of participants with an amputation of less than 6 months at inclusion, the intensity of phantom sensations will be re-assessed using the 3-point ordinal scale.

    Time frame: The first day of the study and during the 6-month follow-up visit.

  11. Walking speed under laboratory conditions

    The participant's average walking speed, measured in meters per second (m/s). The measurement will be collected using inertial measurement units (IMUs) and/or a Vicon motion capture system while the participant walks on hard ground or on a treadmill at their self-selected speed.

    Time frame: The first day of the study for the control group and the second day of the study for participants with amputation

  12. Step length symmetry index.

    Gait symmetry will be calculated based on the stride length of the affected (or corresponding) limb and the healthy limb. The symmetry index is a unitless ratio (or percentage) that quantifies the difference between the two limbs. A value of 1 (or 100%) indicates perfect symmetry. Measured using inertial measurement units or the Vicon system.

    Time frame: The first day of the study for the control group and the second day of the study for participants with amputation

  13. Surface area and intensity of induced phantom sensation maps

    For each type of stimulation, the number of 3×3 cm areas of the residual limb eliciting phantom sensations is counted and the total surface area (cm²) is calculated (number × 9). For each reactive area, the participant rates the intensity of the induced sensation on a three-level ordinal scale (weak, medium, strong).

    Time frame: 2nd or 3rd day of the study depending on whether the participant with an amputation was included in phase 2 or not and during the 6-month follow-up visit.

  14. Preferred socket condition

    At the end of Phase 4, participants indicate which condition (usual socket or modified socket) they perceive as most facilitating for walking.

    Time frame: Day 7 of the study

  15. Spatiotemporal gait parameters in ecological situation

    Walking speed (m/s), cadence (steps/min) and step symmetry index measured with inertial sensors and pressure insoles during the predefined indoor/outdoor course, compared between the usual socket and the modified socket.

    Time frame: Days 4 to 7 to the study

  16. Characterization of phantom limb sensations

    Composite assessment of phantom limb sensations via a semi-structured interview: type of sensation, location, intensity (weak, medium, strong) and perceived influence on walking (helpful, neutral, disturbing).

    Time frame: The first day of the study

  17. Step length

    Step length (m) of the prosthetic and intact limbs during level walking at self-selected speed.

    Time frame: The first day of the study for the control group and the second day of the study for participants with amputation

  18. stance and swing phase durations

    Stance and swing phase durations of each limb, expressed as % of gait cycle.

    Time frame: The first day of the study for the control group and the second day of the study for participants with amputation

  19. Functional Ambulation Performance Score (FAPS)

    Composite score computed from spatiotemporal parameters, ranging from 30 (highly pathological gait) to 100 (healthy gait).

    Time frame: The first day of the study for the control group and the second day of the study for participants with amputation

  20. Enhanced Gait Variability Index (EGVI)

    Composite gait variability score computed from step-to-step spatiotemporal parameters; values between 95 and 105 indicate healthy variability.

    Time frame: The first day of the study for the control group and the second day of the study for participants with amputation

  21. Raw NASA-TLX score (RTLX)

    Perceived cognitive workload during walking, computed as the mean of the six NASA-TLX dimensions, each rated 0-10 (higher = higher workload).

    Time frame: The first day of the study for the control group and the second day of the study for participants with amputation

  22. Perceived exertion (Borg CR10)

    Borg CR10 score (0-10; higher = greater exertion), collected after each walking condition.

    Time frame: The first day of the study for the control group and the second day of the study for participants with amputation

  23. Perceived interaction between phantom sensations and walking

    Visual analog scale from -5 (very disturbing) to +5 (very helpful), completed by participants with phantom sensations after each walking condition; analyzed as a continuous variable

    Time frame: the second day of the study for participants with amputation

Other outcomes

  1. Maximum vertical reaction force during walking.

    The maximum force exerted on the ground with each step, measured in Newtons (N) or as a percentage of body weight (%BW). The measurement will be taken using force platforms (AMTI), pressure insoles (Loadsol), or an instrumented mat (Zeno).

    Time frame: The first day of the study for the control group and the second day of the study for participants with amputation

07

Study locations

1 of 1 sites recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2024 (actual). Primary completion is estimated for Sep 2028, 48 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 21, 2025
First posted
Sep 25, 2025
StartActual
Sep 16, 2024
Primary completionEst.
Sep 30, 2028
CompletionEst.
Sep 30, 2030
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Enrollment
228→248
Nov 3, 2026
Interventions
Removed Exploration of the areas of the brain activated during referred sensations. Arms added: Amputees w-o SF·Amputees H-SF·Amputees B-SF·Amputees N-SF; arms removed: TT·TF
Nov 3, 2026
Primary outcomes
3 added, 8 removed
What changed in the outcomes
  • AddedPrevalence of non-painful phantom sensations during walkingTime frame: The first day of the study
  • AddedDouble support time during level walking at self-selected speedTime frame: The first day of the study for the control group and the second day of the study for participants with amputation
  • AddedWithin-participant difference in double support time between usual and modified socketTime frame: Days 4 to 7 of the study
  • RemovedCharacterization of phantom limb sensationsTime frame: The first day of the study
  • RemovedWalking speed under laboratory conditionsTime frame: The first day of the study for the control group and the second day of the study for participants with amputation
  • RemovedStep length symmetry index.Time frame: The first day of the study for the control group and the second day of the study for participants with amputation
  • RemovedChanges in the surface area of sensory maps referred to the residual limbTime frame: 2nd or 3rd day of the study depending on whether the participant with an amputation was included in phase 2 or not and during the 6-month follow-up visit.
  • RemovedChange in the average intensity of reported phantom sensations.Time frame: 2nd or 3rd day of the study depending on whether the participant with an amputation was included in phase 2 or not and during the 6-month follow-up visit.
  • RemovedLocalization of the cortical source of somatosensory evoked potentials (SEPs) during stimulation of referred sensation areasTime frame: The second day of the study for participants with amputation
  • RemovedParticipant's subjective preference for one of the four socket conditions tested.Time frame: Day 7 of the study
  • RemovedChange in the spatiotemporal parameters of walking in ecological situationsTime frame: Days 4 to 7 to the study
Nov 3, 2026
Secondary outcomes
14 added, 2 removed
What changed in the outcomes
  • AddedWalking speed under laboratory conditionsTime frame: The first day of the study for the control group and the second day of the study for participants with amputation
  • AddedStep length symmetry index.Time frame: The first day of the study for the control group and the second day of the study for participants with amputation
  • AddedSurface area and intensity of induced phantom sensation mapsTime frame: 2nd or 3rd day of the study depending on whether the participant with an amputation was included in phase 2 or not and during the 6-month follow-up visit.
  • AddedPreferred socket conditionTime frame: Day 7 of the study
  • AddedSpatiotemporal gait parameters in ecological situationTime frame: Days 4 to 7 to the study
  • AddedCharacterization of phantom limb sensationsTime frame: The first day of the study
  • AddedStep lengthTime frame: The first day of the study for the control group and the second day of the study for participants with amputation
  • Addedstance and swing phase durationsTime frame: The first day of the study for the control group and the second day of the study for participants with amputation
  • AddedFunctional Ambulation Performance Score (FAPS)Time frame: The first day of the study for the control group and the second day of the study for participants with amputation
  • AddedEnhanced Gait Variability Index (EGVI)Time frame: The first day of the study for the control group and the second day of the study for participants with amputation
  • AddedRaw NASA-TLX score (RTLX)Time frame: The first day of the study for the control group and the second day of the study for participants with amputation
  • AddedPerceived exertion (Borg CR10)Time frame: The first day of the study for the control group and the second day of the study for participants with amputation
  • AddedPerceived interaction between phantom sensations and walkingTime frame: the second day of the study for participants with amputation
  • RemovedAnalysis of muscle co-activation in the lower limbs and trunk during walking.Time frame: The first day of the study for the control group and the second day of the study for participants with amputation
  • RemovedMaximum vertical reaction force during walking.Time frame: The first day of the study for the control group and the second day of the study for participants with amputation
  • Addedother outcomeMaximum vertical reaction force during walking.Time frame: The first day of the study for the control group and the second day of the study for participants with amputation
Nov 3, 2026
Sponsor
Collaborators added: Centre de rééducation Maguelone·Fondation Saint-Hélier; collaborators removed: Centre Orthopédique Maguelone·Institut des Sciences du Mouvement
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    Enrollment 228→248
    Primary outcomes 3 added, 8 removed
    What changed in the outcomes
    • AddedPrevalence of non-painful phantom sensations during walkingTime frame: The first day of the study
    • AddedDouble support time during level walking at self-selected speedTime frame: The first day of the study for the control group and the second day of the study for participants with amputation
    • AddedWithin-participant difference in double support time between usual and modified socketTime frame: Days 4 to 7 of the study
    • RemovedCharacterization of phantom limb sensationsTime frame: The first day of the study
    • RemovedWalking speed under laboratory conditionsTime frame: The first day of the study for the control group and the second day of the study for participants with amputation
    • RemovedStep length symmetry index.Time frame: The first day of the study for the control group and the second day of the study for participants with amputation
    • RemovedChanges in the surface area of sensory maps referred to the residual limbTime frame: 2nd or 3rd day of the study depending on whether the participant with an amputation was included in phase 2 or not and during the 6-month follow-up visit.
    • RemovedChange in the average intensity of reported phantom sensations.Time frame: 2nd or 3rd day of the study depending on whether the participant with an amputation was included in phase 2 or not and during the 6-month follow-up visit.
    • RemovedLocalization of the cortical source of somatosensory evoked potentials (SEPs) during stimulation of referred sensation areasTime frame: The second day of the study for participants with amputation
    • RemovedParticipant's subjective preference for one of the four socket conditions tested.Time frame: Day 7 of the study
    • RemovedChange in the spatiotemporal parameters of walking in ecological situationsTime frame: Days 4 to 7 to the study
    Secondary outcomes 14 added, 2 removed
    What changed in the outcomes
    • AddedWalking speed under laboratory conditionsTime frame: The first day of the study for the control group and the second day of the study for participants with amputation
    • AddedStep length symmetry index.Time frame: The first day of the study for the control group and the second day of the study for participants with amputation
    • AddedSurface area and intensity of induced phantom sensation mapsTime frame: 2nd or 3rd day of the study depending on whether the participant with an amputation was included in phase 2 or not and during the 6-month follow-up visit.
    • AddedPreferred socket conditionTime frame: Day 7 of the study
    • AddedSpatiotemporal gait parameters in ecological situationTime frame: Days 4 to 7 to the study
    • AddedCharacterization of phantom limb sensationsTime frame: The first day of the study
    • AddedStep lengthTime frame: The first day of the study for the control group and the second day of the study for participants with amputation
    • Addedstance and swing phase durationsTime frame: The first day of the study for the control group and the second day of the study for participants with amputation
    • AddedFunctional Ambulation Performance Score (FAPS)Time frame: The first day of the study for the control group and the second day of the study for participants with amputation
    • AddedEnhanced Gait Variability Index (EGVI)Time frame: The first day of the study for the control group and the second day of the study for participants with amputation
    • AddedRaw NASA-TLX score (RTLX)Time frame: The first day of the study for the control group and the second day of the study for participants with amputation
    • AddedPerceived exertion (Borg CR10)Time frame: The first day of the study for the control group and the second day of the study for participants with amputation
    • AddedPerceived interaction between phantom sensations and walkingTime frame: the second day of the study for participants with amputation
    • RemovedAnalysis of muscle co-activation in the lower limbs and trunk during walking.Time frame: The first day of the study for the control group and the second day of the study for participants with amputation
    • RemovedMaximum vertical reaction force during walking.Time frame: The first day of the study for the control group and the second day of the study for participants with amputation
    • Addedother outcomeMaximum vertical reaction force during walking.Time frame: The first day of the study for the control group and the second day of the study for participants with amputation
    Interventions Removed Exploration of the areas of the brain activated during referred sensations. Arms added: Amputees w-o SF·Amputees H-SF·Amputees B-SF·Amputees N-SF; arms removed: TT·TF
    Sponsor Collaborators added: Centre de rééducation Maguelone·Fondation Saint-Hélier; collaborators removed: Centre Orthopédique Maguelone·Institut des Sciences du Mouvement
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07191795
Lead sponsor
Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est
Collaborators
Clinique Chantecler, Centre Helio Marin, Institut universitaire de réadaptation Valmante Sud, Centre de rééducation Maguelone, Fondation Saint-Hélier
Responsible party
Sponsor
First posted
Sep 25, 2025
Start date
Sep 16, 2024
Primary completion
Sep 30, 2028 (estimated)
Completion
Sep 30, 2030 (estimated)
Last update
Nov 3, 2026

Study contacts

Jonathan J Pierret, PhD
Contact
jonathan.pierret@ugecam.assurance-maladie.fr
+33383526761
Amelie A Touillet
principal investigator · Institut Régional de Médecine Physique et de Réadaptation

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion